Migraine Relief: Are Ordinary Painkillers Enough?
2 Oct 2026
A 2026 network meta-analysis of 25 trials and 22,100 people found that the acetaminophen-aspirin-caffeine combination and ibuprofen 400 mg gave strong two-hour relief in acute episodic migraine, with results broadly comparable to the newer drug lasmiditan 200 mg for pain freedom [1]. For many people, a well-timed ordinary painkiller is a reasonable first step. But migraine that is frequent, disabling or not settling needs a proper review.
Migraine Relief at a glance
- Study: network meta-analysis of 25 randomised trials, 22,100 participants, comparing over-the-counter and newer prescription drugs [1].
- Pain relief at 2 hours: the aspirin-paracetamol-caffeine combination ranked highest, followed by ibuprofen 400 mg and 200 mg [1].
- Nausea: rimegepant 75 mg had the strongest effect on nausea [1].
- Heart risk: about 20% of people with migraine have a cardiovascular reason to avoid triptans [2].
- Eye health: a separate review linked migraine with a modestly higher glaucoma risk (OR 1.28), but cannot show cause [3].
What did the 2026 comparison find?
Few trials compare over-the-counter painkillers directly with newer drugs, so researchers used a network meta-analysis, a method that links trials through shared comparators. They pooled 25 randomised trials covering five interventions in 22,100 people [1]. Against placebo, the acetaminophen, aspirin and caffeine (AAC) combination gave the best two-hour pain relief (relative risk 1.76), followed by ibuprofen at 400 mg and 200 mg [1].
For being completely pain-free at two hours, AAC, ibuprofen 400 mg and lasmiditan 200 mg showed broadly comparable benefits [1]. AAC also did best for light and sound sensitivity, while rimegepant 75 mg had the strongest effect on nausea [1].
Does this mean newer drugs are not needed?
No. It means the old options deserve more respect than they get. The authors describe ordinary painkillers as effective, accessible options to use alongside the newer oral agents [1]. The analysis compared drug effects in clinical trials. It did not test long-term safety, or how often a person can safely use each pill. It also could not say who responds best to which drug, and the authors call for larger studies to personalise treatment [1].
What if triptans are not safe for you?
Triptans narrow blood vessels, which is why roughly 20% of people with migraine have a heart or circulation reason to avoid them [2]. A 2026 meta-analysis looked at lasmiditan, a newer drug that does not narrow vessels. In three trials with 5,126 participants, lasmiditan roughly doubled the odds of being pain-free at two hours compared with placebo (OR 2.09) and no vasoconstrictive events were seen [2]. Dizziness, sleepiness and tingling were the common side effects, and the authors note that lasmiditan was voluntarily withdrawn from the market [2].
That withdrawal is a reminder that options change. If triptans are unsuitable, ask your doctor which alternatives are currently available in India and appropriate for your heart health.
Is migraine linked to eye problems?
A 2026 review of 19 studies with more than 3.6 million people found a statistically significant association between migraine and glaucoma (odds ratio 1.28). After adjusting for possible missing studies, the estimate was slightly lower (1.23) [3]. The authors say this is an association and that better prospective studies are needed to understand causality [3]. Do not panic. Most people with migraine will not develop glaucoma, but if you have migraine and a family history of glaucoma, mention it at your next eye check.
When does migraine need a specialist review?
Seek review when attacks are frequent, when pills are needed on many days of the month, when treatment is not working, or when the pattern changes. Sudden severe headache, weakness, trouble speaking or loss of vision needs urgent medical attention, so go to an emergency department.
| Treatment | Strongest finding | Note |
|---|---|---|
| Acetaminophen + aspirin + caffeine | Best 2-hour pain relief (RR 1.76) and best on light and sound sensitivity [1] | Over-the-counter |
| Ibuprofen 400 mg | Consistent benefit across 2-hour outcomes [1] | Over-the-counter |
| Lasmiditan 200 mg | Pain freedom broadly comparable to AAC and ibuprofen [1] | Not a vasoconstrictor [2]; later withdrawn from the market [2] |
| Rimegepant 75 mg | Strongest effect on nausea [1] | Newer prescription option |
Acute migraine treatments in the 2026 network meta-analysis [1].
Getting help in Delhi
At Brain Bridge Clinic in Safdarjung Enclave, New Delhi, a migraine assessment starts with a detailed history: how often attacks come, what triggers them, which medicines you already use and how they work for you. The plan can combine acute and preventive medicine management with education on triggers and sleep. Dr. Amit Tomar and the team will explain which options suit you, particularly if you have heart risk factors. If migraine is affecting your work or family life, you are welcome to book an assessment.
Related pages: Migraine Cluster Headache, Preventive Acute Medication Management, Psychoeducation.
Frequently asked questions
Is ibuprofen effective for migraine?
In a 2026 network meta-analysis, ibuprofen 400 mg gave consistent benefit across two-hour outcomes compared with placebo [1]. Your doctor can advise how often it is safe for you to take it.
Are over-the-counter painkillers as good as prescription migraine drugs?
For pain freedom at two hours, aspirin-paracetamol-caffeine and ibuprofen 400 mg were broadly comparable to lasmiditan 200 mg in the analysis [1]. Prescription drugs may still suit you better, for example if you get severe nausea.
Can I take triptans if I have heart disease?
Triptans narrow blood vessels, and about 20% of people with migraine have a cardiovascular reason to avoid them [2]. Do not take them without checking with your doctor.
Does migraine cause glaucoma?
A 2026 review found an association (OR 1.28) but could not show that migraine causes glaucoma [3]. Regular eye checks are sensible.
Is lasmiditan available?
A 2026 analysis noted that lasmiditan was voluntarily withdrawn from the market [2]. Ask your doctor what alternatives exist.
References
- Mitra A, Franks B, Petruschke R, et al. Comparative efficacy of AAC and ibuprofen versus lasmiditan, ubrogepant, and rimegepant for the acute treatment of episodic migraine in adults: a systematic review and network meta-analysis. Frontiers in neurology. 2026;17:1884713. doi:10.3389/fneur.2026.1884713. PMID 42812259.
- Biswas S, Vasireddy S, Srivastava Y, et al. Efficacy and cardiovascular safety of lasmiditan in patients with cardiovascular risk factors: A systematic review and meta-analysis with updated synthesis of triptan safety data. Headache. 2026;66(9):2156-2172. doi:10.1111/head.70182. PMID 42723270.
- Lu S, Ye X, Chen S, et al. Migraine and the risk of glaucoma: a systematic review and meta-analysis. Frontiers in neurology. 2026;17:1890818. doi:10.3389/fneur.2026.1890818. PMID 42846265.